review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Alejandro Villarino | Q43171336 |
P2093 | author name string | David Artis | |
Christopher A Hunter | |||
Phillip Scott | |||
P2860 | cites work | A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 |
Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment | Q24301442 | ||
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 | Q24307411 | ||
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 | ||
Development of Th1-type immune responses requires the type I cytokine receptor TCCR | Q28591931 | ||
The lineage decisions of helper T cells | Q29614841 | ||
STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma | Q33887011 | ||
T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells | Q33952975 | ||
Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice | Q34430392 | ||
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
The immunology of susceptibility and resistance to Leishmania major in mice | Q34988360 | ||
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses | Q35582560 | ||
Understanding the pro- and anti-inflammatory properties of IL-27. | Q35829406 | ||
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism | Q36350176 | ||
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens | Q36355614 | ||
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets | Q36355870 | ||
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes | Q36356764 | ||
Recombinant interleukin 12 cures mice infected with Leishmania major | Q36361742 | ||
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response | Q36361808 | ||
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii | Q36367127 | ||
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation | Q36369420 | ||
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice | Q40705435 | ||
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells | Q40757721 | ||
Toxoplasmosis in patients with cancer | Q40797537 | ||
Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii | Q40860927 | ||
Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones | Q42070272 | ||
IL-4-deficient Balb/c mice resist infection with Leishmania major | Q42943751 | ||
IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. | Q43466126 | ||
WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production | Q44721986 | ||
Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis | Q44788662 | ||
In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting | Q45069275 | ||
Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells | Q45730504 | ||
WSX-1: a key role in induction of chronic intestinal nematode infection | Q47371263 | ||
The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection | Q47388000 | ||
Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. | Q47810571 | ||
Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. | Q51065721 | ||
P304 | page(s) | 106-114 | |
P577 | publication date | 2004-12-01 | |
P1433 | published in | Immunological Reviews | Q15724582 |
P1476 | title | The role of IL-27 in the development of T-cell responses during parasitic infections | |
P478 | volume | 202 |
Q98177694 | C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection |
Q43605525 | CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell suppression through an IL-2-related mechanism but independently of IL-10. |
Q37471208 | Cigarette Smoke Induction of Interleukin-27/WSX-1 Regulates the Differentiation of Th1 and Th17 Cells in a Smoking Mouse Model of Emphysema |
Q34472010 | Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors |
Q39945236 | Cytokine Signatures Associated With Early Onset, Active Lesions and Late Cicatricial Events of Retinochoroidal Commitment in Infants With Congenital Toxoplasmosis. |
Q41963983 | Disruption of interleukin-27 signaling results in impaired gamma interferon production but does not significantly affect immunopathology in murine schistosome infection |
Q38520459 | Distinct transcriptional profiles characterize oral epithelium-microbiota interactions |
Q33670036 | IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. |
Q27335548 | IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection |
Q36370603 | IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis |
Q35072420 | IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling |
Q54358247 | IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10. |
Q34488727 | IL-27-induced modulation of autoimmunity and its therapeutic potential |
Q41313244 | Interferon Gamma in African Trypanosome Infections: Friends or Foes? |
Q34681102 | Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. |
Q38962452 | Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review |
Q47992175 | Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria |
Q42129243 | Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines |
Q36481079 | STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance |
Q41641061 | Selective depletion of CD11c+ CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. |
Q34482169 | Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27 |
Q36730742 | Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma |
Q36642440 | T Cell Vaccinology: Beyond the Reflection of Infectious Responses |
Q37747271 | Thymic DCs derived IL-27 regulates the final maturation of CD4(+) SP thymocytes |
Q35148364 | Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding |
Q34157182 | Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production. |
Q36437505 | What makes a good anti-inflammatory drug target? |
Search more.